589.48
price down icon1.45%   -8.68
after-market アフターアワーズ: 587.92 -1.56 -0.26%
loading
前日終値:
$598.16
開ける:
$602.35
24時間の取引高:
1.44M
Relative Volume:
1.27
時価総額:
$61.41B
収益:
$14.21B
当期純損益:
$4.46B
株価収益率:
14.86
EPS:
39.68
ネットキャッシュフロー:
$3.56B
1週間 パフォーマンス:
+1.56%
1か月 パフォーマンス:
+5.09%
6か月 パフォーマンス:
-15.83%
1年 パフォーマンス:
-50.37%
1日の値動き範囲:
Value
$585.50
$610.45
1週間の範囲:
Value
$570.39
$610.45
52週間の値動き範囲:
Value
$476.49
$1,211.20

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
名前
Regeneron Pharmaceuticals Inc
Name
セクター
Healthcare (1157)
Name
電話
(914) 847-7000
Name
住所
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Name
職員
15,207
Name
Twitter
@regeneron
Name
次回の収益日
2025-08-01
Name
最新のSEC提出書
Name
REGN's Discussions on Twitter

REGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-14 開始されました Rothschild & Co Redburn Buy
2025-06-30 ダウングレード Argus Buy → Hold
2025-05-30 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-05-30 ダウングレード Wells Fargo Overweight → Equal Weight
2025-05-14 アップグレード Citigroup Neutral → Buy
2025-04-22 再開されました Cantor Fitzgerald Overweight
2025-02-05 アップグレード Leerink Partners Market Perform → Outperform
2025-01-16 ダウングレード UBS Buy → Neutral
2024-12-10 再開されました BofA Securities Underperform
2024-11-15 開始されました Wolfe Research Outperform
2024-11-14 開始されました Citigroup Neutral
2024-09-24 ダウングレード Leerink Partners Outperform → Market Perform
2024-03-12 開始されました Bernstein Outperform
2024-01-12 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-11-09 開始されました Deutsche Bank Hold
2023-11-03 アップグレード Raymond James Mkt Perform → Outperform
2023-08-21 アップグレード Canaccord Genuity Hold → Buy
2023-08-21 繰り返されました Oppenheimer Perform
2023-06-28 ダウングレード Canaccord Genuity Buy → Hold
2023-03-27 アップグレード SVB Securities Market Perform → Outperform
2023-03-24 アップグレード Jefferies Hold → Buy
2023-03-23 アップグレード Raymond James Underperform → Mkt Perform
2023-01-30 アップグレード Cowen Market Perform → Outperform
2023-01-20 アップグレード JP Morgan Neutral → Overweight
2022-10-26 ダウングレード Raymond James Mkt Perform → Underperform
2022-10-17 ダウングレード Evercore ISI Outperform → In-line
2022-09-09 アップグレード Jefferies Underperform → Hold
2022-09-09 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-07-25 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-07-13 開始されました Cantor Fitzgerald Neutral
2022-06-06 開始されました Jefferies Underperform
2022-05-23 開始されました SVB Leerink Outperform
2022-01-05 ダウングレード BofA Securities Neutral → Underperform
2022-01-03 アップグレード Bernstein Mkt Perform → Outperform
2021-12-15 ダウングレード Bernstein Outperform → Mkt Perform
2021-12-09 再開されました Wells Fargo Overweight
2021-12-07 再開されました Cowen Market Perform
2021-12-06 開始されました Goldman Buy
2021-11-19 再開されました BMO Capital Markets Outperform
2021-11-05 ダウングレード The Benchmark Company Buy → Hold
2021-06-29 開始されました H.C. Wainwright Buy
2021-01-25 アップグレード BMO Capital Markets Market Perform → Outperform
2021-01-13 アップグレード The Benchmark Company Hold → Buy
2021-01-08 アップグレード Citigroup Neutral → Buy
2020-10-05 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-08-20 ダウングレード The Benchmark Company Buy → Hold
2020-07-09 アップグレード SunTrust Hold → Buy
2020-05-26 アップグレード Wells Fargo Equal Weight → Overweight
2020-04-28 ダウングレード Citigroup Buy → Neutral
2020-04-17 アップグレード The Benchmark Company Hold → Buy
2020-04-08 開始されました The Benchmark Company Hold
2020-03-31 開始されました Wolfe Research Peer Perform
2020-02-27 開始されました Barclays Overweight
2020-02-26 アップグレード Canaccord Genuity Hold → Buy
2020-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2020-02-25 アップグレード Jefferies Hold → Buy
2020-02-11 アップグレード Argus Hold → Buy
2019-12-24 開始されました Raymond James Mkt Perform
2019-12-16 ダウングレード Evercore ISI Outperform → In-line
2019-12-13 アップグレード Credit Suisse Neutral → Outperform
2019-11-12 開始されました SunTrust Hold
2019-11-07 アップグレード Citigroup Neutral → Buy
2019-10-17 再開されました BofA/Merrill Neutral
2019-09-23 アップグレード Guggenheim Neutral → Buy
すべてを表示

Regeneron Pharmaceuticals Inc (REGN) 最新ニュース

pulisher
Aug 20, 2025

Regeneron Surges on FDA Delay as $0.77B Volume Ranks in Top 500 - AInvest

Aug 20, 2025
pulisher
Aug 20, 2025

FDA Pushes Back Eylea HD Review; Regeneron Still Gains - Yahoo Finance

Aug 20, 2025
pulisher
Aug 20, 2025

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 20, 2025
pulisher
Aug 20, 2025

Scholar Rock jumps following Regeneron Eylea update - Seeking Alpha

Aug 20, 2025
pulisher
Aug 20, 2025

Element Capital Management LLC Purchases New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Regeneron's Eylea injection review dates delayed by FDA (REGN) - Seeking Alpha

Aug 20, 2025
pulisher
Aug 20, 2025

Aberdeen Group plc Acquires 56,746 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Fox Run Management L.L.C. Buys Shares of 1,734 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Regeneron Pharmaceuticals Announces FDA Extension for EYLEA HD® Regulatory Submissions to Q4 2025 - Quiver Quantitative

Aug 20, 2025
pulisher
Aug 20, 2025

Regeneron Says FDA Will Take More Time to Review Its Two Eylea HD Submissions - Stocktwits

Aug 20, 2025
pulisher
Aug 20, 2025

FDA Extends Review Timeline: Regeneron's EYLEA HD Faces Q4 2025 Decision for Expanded Uses - Stock Titan

Aug 20, 2025
pulisher
Aug 20, 2025

RWA Wealth Partners LLC Decreases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Qtron Investments LLC - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

500 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Corient IA LLC - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

American Century Companies Inc. Purchases 14,921 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Independent Advisor Alliance Buys 472 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025
pulisher
Aug 19, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Public Sector Pension Investment Board - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Kovitz Investment Group Partners LLC Buys 3,090 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Cambiar Investors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Ethic Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Gulf International Bank UK Ltd Sells 2,097 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

National Pension Service Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 19, 2025
pulisher
Aug 18, 2025

Sienna Gestion Has $5.65 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Regeneron Stock Slumps as Trading Volume Plunges 31% to 440M Ranking 207th in U.S. Activity - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

85,929 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by Tocqueville Asset Management L.P. - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Leo Keeps On Profitable Path With Solid H1 Sales Growth - insights.citeline.com

Aug 18, 2025
pulisher
Aug 18, 2025

Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.

Aug 18, 2025
pulisher
Aug 18, 2025

State of New Jersey Common Pension Fund D Trims Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Dimensional Fund Advisors LP Sells 15,838 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Prudential PLC - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Aug 18, 2025
pulisher
Aug 17, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by E Fund Management Co. Ltd. - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

1,038 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by S Bank Fund Management Ltd - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Tokio Marine Asset Management Co. Ltd. Has $9.55 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Russell Investments Group Ltd. Has $93.08 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Resona Asset Management Co. Ltd. Acquires 1,225 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

How volatile is Regeneron Pharmaceuticals Inc. stockTrade Volume Report & Technical Confirmation Alerts - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Increased to Strong-Buy at Redburn Atlantic - MarketBeat

Aug 17, 2025
pulisher
Aug 16, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated at Rothschild & Co Redburn - MarketBeat

Aug 16, 2025
pulisher
Aug 16, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Invesco Ltd. - MarketBeat

Aug 16, 2025
pulisher
Aug 15, 2025

Regeneron Pharmaceuticals Inc. Building a Base Near SupportMarket Performance Summary & Growth Oriented Trading Recommendations - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

Cary Street Partners Financial LLC Sells 959 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Aug 15, 2025
pulisher
Aug 15, 2025

Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Potential Game Changer - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Regeneron’s Phase 3 Study on Garetosmab: A Potential Game-Changer for FOP Treatment - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Can Eylea HD and Dupixent Profits Revive Regeneron Stock? - Yahoo Finance

Aug 15, 2025
pulisher
Aug 15, 2025

Mizuho Securities USA LLC Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Aug 15, 2025
pulisher
Aug 15, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $812.00 Price Target at Truist Financial - MarketBeat

Aug 15, 2025

Regeneron Pharmaceuticals Inc (REGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Regeneron Pharmaceuticals Inc (REGN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
McCourt Marion
EVP Commercial
Nov 01 '24
Option Exercise
381.40
1,000
381,400
13,931
McCourt Marion
EVP Commercial
Nov 01 '24
Sale
844.61
1,000
844,610
12,931
$454.38
price down icon 2.82%
$660.00
price down icon 0.56%
biotechnology ONC
$313.67
price down icon 0.10%
$131.88
price down icon 0.54%
$110.88
price up icon 0.10%
大文字化:     |  ボリューム (24 時間):